TCT-504 Long Term Outcomes Among Patients With ‘False-positive’ STEMI Activations: A Report From The ACTIVATE-SF Registry  by Turner, Tyson et al.
clinical characteristics and outcome for patients undergoing small versus large culprit
vessel PPCI in our unit.
Methods: We included all patients who underwent PPCI in our unit between Sept 2009
and May 2011. They were divided into two groups according to the size of the largest
balloon or stent used in the culprit lesion.
Results: Of the 1132 patients who underwent PPCI in our unit during the study period,
we excluded 30 (2.7%) patients who did not have either a balloon or stent used in the
culprit lesion. Of the remaining 1102 patients, 569 (51.6%) had small (3 mm) vessel
PPCI and 533 (48.4%) had large (3 mm) vessel PPCI. Patients with small vessel PPCI
were significantly older, more likely to be female and have anterior STEMI with less use
of thrombectomy device, but with significantly higher drug eluting stent (DES) usage.
There was significantly higher in-hospital mortality (5.3% vs 2.8%, OR 1.9, 95% CI 1-3.6,
p 0.047), 30-day mortality (8.4% vs 3.6%,OR 2.5, 95% CI 1.4-4.3, p 0.0009) and 30-day
stent thrombosis (1.2% vs 0, p 0.02) in the small vessel PPCI group compared to large
vessel PPCI group. On binary logistic regression analysis of small vessel PPCI patients
(covariates used: female sex, Age 75 yrs, cardiogenic shock, diabetes, LAD PCI and
DES use), the positive predictors of 30-day mortality were age75 yrs (OR 6.1, 95% CI
2.9 to 12.5, p0.0001) and cardiogenic shock (OR 9.9, 95% CI 4.3-22.6, p0.0001) with
DES use (OR 0.4, 95% CI 0.2-0.8, p 0.01) being the only negative predictor of mortality.
N (%)
Small (<3 mm)
vessel
Large (> 3 mm)
vessel
p valueN 569 N 533
Age (meanSD,
range)
66.813.5, 25-96 62.913.1, 26-99 0.0001
Age  75 yrs 172 (30.2) 94 (17.6) 0.0001
Female 203 (35.7) 94 (17.6) 0.0001
Diabetes 68 (11.8) 63 (11.8) 1.0
Cardiogenic shock 42 (7.4) 42 (7.9) 0.73
Previous MI 65 (11.4) 69 (12.9) 0.46
Previous PCI 33 (5.8) 42 (7.9) 0.19
Previous CABG 11 (1.9) 16 (3) 0.33
LAD PCI 293 (51.5) 218 (40.9) 0.0005
Thrombectomy use 363 (63.8) 424 (79.5) 0.0001
Drug eluting stent use
(at least one)
363 (63.8) 289 (54.2) 0.001
Conclusions: In this large consecutive PPCI series from a single center, small culprit
vessel size was associated with significantly higher 30-day mortality, more than double
the mortality seen in patients with a large culprit vessel.
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Background: Elderly constitute an increasing proportion of all patients, who are
admitted for ACS to the hospital, but on the other hand increased age has been identified
as an important risk factor for death or recurrent MI in this subset. Furthermore elderly
patients are at higher risk for complications with interventional procedures, therefore the
overall benefit in such procedures, facing a limited life expectancy in elderly patients
anyway, still remains uncertain. The purpose of this study was to identify predictors of
longtime survival in either interventionally or conservatively treated elderly patients with
ACS in a large consecutive series of elderly ( 75 years).
Methods: Between 01/05 and 11/07 1001 patients  75 ys. were admitted with the
diagnosis of ACS in our hospital. Records were evaluated and patients were identified on
the basis of their discharge diagnosis. Adverse outcome, defined as the appearance of
death, myocardial infarction, complicated hospital stay, pneumonia and interventional
complications like bleeding, stroke and reinfarction etc. was evaluated. Using a multi-
variate regression analysis, factors which predicted long-time mortality were identified.
Results: Out of 1001 patients (mean age 815 Jahre, 512 (51.1% female), Killip-class
1,40,75, EF 4715%) 776 [77.5 %] were treated invasively; wherease 247 [22.5%]
were teated conservatively. Mean survival for conservatively treated NSTEMI patients
was 78953 vs. 123729 in the invasively treated patients, in the STEMI group survival
was 706128 for conservatively and 123844 days for interventionally treated patients
respectively (p0.001). As predictors of long term mortality we identified renal failure
((p0.001), insulin-treated Diabetes (p0.001); chronic obstructive pulmonary disease
(p0.002), Grace-Score (p0.002) intervention (p0.003), increased body mass index
(p0.018) and age (p0.042).
Conclusions: In our large data base of 1001 patients age was not the main predictor of
long-time mortality. Therefore advanced age should not be the main factor in decision
making for conservative or invasive treatment in elderly patients with ACS and an
invasive strategy should be offered also to elderly patients.
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Background: An emphasis on sensitivity in the diagnosis of ST-segment elevation
myocardial infarction necessitates a certain degree of ‘false positive’ diagnoses. Little is
known about the long-term outcomes of those ultimately found to lack a culprit coronary
artery occlusion despite a putative STEMI diagnosis.
Methods: We analyzed a registry of all STEMI diagnoses established in the Emergency
Department (ED) at two urban centers from 2008 to 2011. Subsequent death, ED visits,
hospitalizations, and cardiac procedures at our study centers following index hospitaliza-
tion were evaluated. Statistical analyses were performed using Student’s t tests and
regression analyses.
Results: During a median follow up of 20 months (IQR12.2-29.6 months), 13 of 153
‘false positive’ STEMI diagnoses died as compared to 32 of 248 ‘true positives’ (p 
0.091) (Figure 1). After adjusting for traditional risk factors, all-cause mortality was not
statistically different between ‘true’ and ‘false’ STEMI diagnoses (AOR 2.26, 95% CI
0.21-24.23, p0.499). However, false positive status was associated with a significantly
higher likelihood of a recurrent visit to the emergency department (AOR 2.73, 95% CI
1.24-6.02 p0.01), and an increased rate of re-hospitalization (1.04 additional hospital-
izations, 95% CI 0.21-1.86, p0.01) though they also had a trend towards fewer
subsequent myocardial infarctions (AOR 0.92, 95% CI 0.17 to 0.01, p0.07).
Conclusions: Patients with ‘false positive’ STEMI diagnoses have rates of long term
all-cause mortality comparable to a ‘true’ STEMIs population and have potentially greater
rates of recurrent resource utilization. Patients diagnosed with a putative STEMI but found
to lack a culprit coronary artery occlusion on angiography remain at great risk for
subsequent events and require further study.
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Background: The aim of this study was to investigate the effects of baseline anaemia on
the outcome of patients treated by primary percutaneous intervention (PPCI) for ST
elevation myocardial infarction.
Methods: We undertook a retrospective cohort study of 2418 STEMI patients treated
with PPCI between January 2004 and August 2010 at a single centre. We investigated the
outcome of patients with anaemia compared to patients with a normal haemoglobin level.
Anaemia was defined according to the WHO definition of haemoglobin (Hb) less than 12
g/dl for females and 13 g/dl for males. We also calculated hazard ratios (HRs) using a
stratified model according to haemoglobin level.
Results: 471 (19%) patients were anaemic at presentation. The anaemic cohort were
older (72.2 vs. 62.4, p0.0001), had higher incidence of diabetes (28% vs. 16%,
p0.0001), hypertension (57% vs. 43%, p0.01), hypercholesterolaemia (48% vs. 40%,
p0.007), previous PCI (15% vs. 9%, p0.0001), previous MI (23% vs. 12%, p0.002)
and cardiogenic shock (12% vs. 5%, P0.0001). Over a mean follow-up period of 3-years
there was significantly higher all cause mortality in the anaemic group compared to the
normal Hb group (20.4% vs. 13.5%, p0.0001). However, after adjustment for all
variables using multivariate analysis, anaemia (based on the WHO definitions) was not an
independent predictor of mortality or major adverse cardiac events (MACE) over the
follow-up period. However, when we used a stratified model by g/dL we found that in
men there was an increased risk of adverse outcome with low Hb. There appeared to be
a threshold value of haemoglobin (13 g/dL) associated with increased risk. Although a
similar trend was observed for women no significant difference was observed.
Conclusions: Patients with anaemia undergoing primary PCI are at higher risk of an
adverse outcome. Anaemia is a simple and powerful marker of poor prognosis. Although
after multivariate analysis, anaemia (based on WHO definitions) does not appear to be an
independent predictor of all-cause mortality or MACE after primary PCI, in men there
appears to be a threshold value of Hb, below which there is an associated increased risk.
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Background: The aim of our study was to determine the short and long-term outcomes
between patients undergoing PPCI during ‘normal hours’ (i.e. In-hours) versus ‘out-of-
hours’. Our primary end point was mortality with a follow-up upto five years.
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